Medicinal Products

Lioresal 25 mg tablete

Name Lioresal 25 mg tablete
Marketing Authorisation Number HR-H-455944140
Active Substance baklofen
Composition jedna tableta sadrži 25 mg baklofena
Pharmaceutical Form tableta
Manufacturer Novartis Pharma GmbH, Nürnberg, Njemačka
Novartis Farmacéutica S.A., Barcelona, Španjolska
Marketing Authorisation Holder Novartis Hrvatska d.o.o., Radnička cesta 37b, Zagreb, Hrvatska
Marketing Authorisation Date 27.07.2017
MA Period of Validity unlimited
Classification Number UP/I-530-09/16-02/323
Registration Number 381-12-01/30-17-03
Prescription na recept
Type of prescription ponovljivi recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code M03BX01
Medicinal product marketed in the Croatia Da
SmPC download
PL download

Packaging

Back